Management of atrial fibrillation.
Lafuente-Lafuente
Carmelo
C
Service de Médecine A, Hôpital Lariboisière, Université Paris 7, France. c.lafuente@nodo3.net
Mahé
Isabelle
I
Extramiana
Fabrice
F
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000628:therapy*; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D010138:Pacemaker, Artificial; D016032:Randomized Controlled Trials as Topic; D014859:Warfarin / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin